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A Novel Two-Component Signaling System Facilitates Uropathogenic
Escherichia coli's Ability to Exploit Abundant Host Metabolites
Abstract
wo-component signaling systems (TCSs) are major mechanisms by which bacteria adapt to environmental
conditions. It follows then that TCSs would play important roles in the adaptation of pathogenic bacteria to
host environments. However, no pathogen-associated TCS has been identified in uropathogenic Escherichia
coli (UPEC). Here, we identified a novel TCS, which we termed KguS/KguR (KguS: α-ketoglutarate
utilization sensor; KguR: α-ketoglutarate utilizationregulator) in UPEC CFT073, a strain isolated from
human pyelonephritis. kguS/kguR was strongly associated with UPEC but was found only rarely among other
E. coli including commensal and intestinal pathogenic strains. An in vivo competition assay in a mouse UTI
model showed that deletion of kguS/kguR in UPEC CFT073 resulted in a significant reduction in its
colonization of the bladders and kidneys of mice, suggesting that KguS/KguR contributed to UPEC fitness in
vivo. Comparative proteomics identified the target gene products of KguS/KguR, and sequence analysis
showed that TCS KguS/KguR and its targeted-genes,c5032 to c5039, are encoded on a genomic island, which
is not present in intestinal pathogenicE. coli. Expression of the target genes was induced by α-ketoglutarate (α-
KG). These genes were further shown to be involved in utilization of α-KG as a sole carbon source under
anaerobic conditions. KguS/KguR contributed to the regulation of the target genes with the direct regulation
by KguR verified using an electrophoretic mobility shift assay. In addition, oxygen deficiency positively
modulated expression of kguS/kguR and its target genes. Taken altogether, this study describes the first
UPEC-associated TCS that functions in controlling the utilization of α-ketoglutarate in vivo thereby
facilitating UPEC adaptation to life inside the urinary tract.
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Abstract
Two-component signaling systems (TCSs) are major mechanisms by which bacteria adapt to environmental conditions. It
follows then that TCSs would play important roles in the adaptation of pathogenic bacteria to host environments. However,
no pathogen-associated TCS has been identified in uropathogenic Escherichia coli (UPEC). Here, we identified a novel TCS,
which we termed KguS/KguR (KguS: a-ketoglutarate utilization sensor; KguR: a-ketoglutarate utilization regulator) in UPEC
CFT073, a strain isolated from human pyelonephritis. kguS/kguR was strongly associated with UPEC but was found only
rarely among other E. coli including commensal and intestinal pathogenic strains. An in vivo competition assay in a mouse
UTI model showed that deletion of kguS/kguR in UPEC CFT073 resulted in a significant reduction in its colonization of the
bladders and kidneys of mice, suggesting that KguS/KguR contributed to UPEC fitness in vivo. Comparative proteomics
identified the target gene products of KguS/KguR, and sequence analysis showed that TCS KguS/KguR and its targeted-
genes, c5032 to c5039, are encoded on a genomic island, which is not present in intestinal pathogenic E. coli. Expression of
the target genes was induced by a-ketoglutarate (a-KG). These genes were further shown to be involved in utilization of a-
KG as a sole carbon source under anaerobic conditions. KguS/KguR contributed to the regulation of the target genes with
the direct regulation by KguR verified using an electrophoretic mobility shift assay. In addition, oxygen deficiency positively
modulated expression of kguS/kguR and its target genes. Taken altogether, this study describes the first UPEC-associated
TCS that functions in controlling the utilization of a-ketoglutarate in vivo thereby facilitating UPEC adaptation to life inside
the urinary tract.
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Introduction
Urinary tract infection (UTI) is one of the most common
bacterial infections in humans and is a significant clinical issue
worldwide. Annually, UTIs are associated with 7 million office
visits, 1 million emergency room visits, 100,000 hospitalizations,
and $1.6 billion in healthcare costs [1]. In fact, ,80–90% of
community-acquired UTIs are caused by uropathogenic Escherichia
coli (UPEC) [2]. Many virulence factors are required for UPEC to
cause UTIs. Typically, UTIs begin with urethral contamination
with UPEC from the bowel [3]. Successful attachment to the
uroepithelium requires specific adhesins including P, type 1 and
other fimbriae (such as F1C, S, M, and Dr fimbriae) [4,5]. UPEC
may then ascend the urethra to enter the bladder and kidneys,
where several highly regulated virulence factors, including
fimbriae, secreted toxins (hemolysin, Vat, Sat, and CNF) and
polysaccharide capsule, may contribute to colonization and
pathogenesis [6]. It is likely that UPEC’s ability to colonize the
urinary tract and cause disease is affected by its adaptive responses
to local environmental cues, including changes in nutrient
availability.
Urine is an important host environment that UPEC encounter
after transition from the intestine to urinary tract. From the
standpoint view of E. coli nutrition, urine is a mixture of amino
acids and small peptides in low concentrations, with the notable
exception of urea, which is abundant [7]. UPEC adapt to growth
in urine by using peptides and amino acids as their primary carbon
source for fitness [8]. About 85% of UPEC strains retain a
complete dsdCXA locus [9] and these genes are responsible for the
detoxification of D-serine allowing UPEC to use D-serine as the
sole carbon and nitrogen source in urine [9]. Iron is another vital
nutrient for UPEC but free iron concentrations in the mammalian
host are extremely low. Consequently, UPEC have evolved
multiple systems and strategies to obtain needed iron during
infection including ent, iro, chu, sit, iutA and fyuA [10–13]. In
addition, the urinary tract is considered to be a nucleotide-
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deficient environment. Study of pyrD and guaA deletion mutants
showed that metabolism of nucleobases is required for UPEC
colonization of the bladder [14,15]. Thus, UPEC metabolism
appears to play a critical role in colonization and invasion of the
host. Therefore, it is not surprising that acquisition of genomic
islands encoding metabolic pathways is often essential for the
colonization of host niches. Gene cluster ttrABC and ttrRS,
responsible for utilizing tetrathionate as an electron acceptor in
the intestine, are encoded on Salmonella enterica subsp. enterica
serotype Typhimurium pathogenicity island II and contribute to
detoxification of tetrathionate and confer a competitive advantage
in growth [16–18]. Gene nixA within a transferable genomic island
in Helicobacter pylori aids in transport of nickel and consequently
results in enhanced activity of urease, a key factor for fitness and
virulence [19–22]. Besides islands encoding iron uptake systems,
no other metabolic island has yet been characterized in UPEC
even though their study would help understand the pathobiology
and facilitate the identification of potential targets for novel
therapeutic approaches to prevent this prevalent pathogen.
The pathways, conferring metabolic adaptation of bacterial
pathogens to the host milieu, are usually controlled by both global
and specific regulators. One mechanism used by most bacterial
pathogens to sense and respond to nutrient availability is two-
component signaling systems (TCSs). TCSs, composed of a
membrane-bound sensor histidine kinase (HK) and a cytoplasmic
response regulator (RR), have been implicated in regulating the
response of bacteria to a wide array of signals and stimuli,
including nutrients, quorum signals, antibiotics, etc. The recogni-
tion of physical or chemical signals by HK sensor domain typically
triggers the modulation of its autophosphorylation activity. The
phosphoryl group is then transferred to the RR, usually a DNA
binding protein that functions by altering gene expression [23,24].
In E. coli K12, more than 30 TCSs have been identified and
characterized to some extent [25–27]. Of these, several were
shown to be involved in UPEC pathogenesis. TCS BarA/UvrY
controlled efficient switching between glycolytic and gluconeogen-
ic carbon sources and contributed to UPEC virulence [28].
Deletion of QseC, the kinase of a well-known TCS QseC/QseB,
dysregulated nucleotide, amino acid, and carbon metabolism and
resulted in attenuation of UPEC virulence [29,30]. In addition,
PhoQ/PhoP [31] and the AirS system [32] have been linked to
UPEC pathogenesis. To date, all TCSs linked to UPEC
pathogenesis have been common to E. coli and are not
pathogen-associated. Given the distinct features of environments
colonized by UPEC, we hypothesize that UPEC may possess
special TCSs that sense urinary tract-specific metabolic signal(s)
and adapt UPEC metabolism to available nutrients.
Here, we describe the first TCS significantly associated with
UPEC and its direct target genes encoded on a small genomic
island. In addition, we demonstrate that the expression of these
island genes is induced in response to a-KG, a nutrient found in
high concentration in renal proximal tubule cells, and that these
genes are involved in the utilization of a-KG under anaerobic
conditions. Our results suggest that KguS/KguR contributes to
UPEC fitness in vivo by facilitating the utilization of a host
abundant metabolite a-KG. This study provides a new perspective
for understanding UPEC pathogenesis in vivo.
Results
Identification of a novel TCS in UPEC CFT073
TCSs enable bacteria to sense, respond, and adapt to a wide
range of environments, stressors, and growth conditions [23].
Since UPEC encounter unique environmental conditions found
within their host, as compared to commensal E. coli and
diarrheagenic E. coli, we hypothesize that specific TCSs may exist
and facilitate UPEC adaptation to certain host niches. Indeed,
analysis of the UPEC CFT073 genome identified a putative TCS
c5041/c5040 by the presence of specific domains in their
respective predicted proteins (Fig. 1). Domains and three-
dimensional structures of C5041 and C5040 were predicted by
the threading method using the I-TASSER online server (http://
zhanglab.ccmb.med.umich.edu/I-TASSER/) and subsequently
refined using four-body contact potentials. C5041 is predicted to
be a typical sensor kinase harboring a dimerization and histidine
phosphotransfer (DHp) domain and a histidine kinase-like ATPase
domain (Fig. 1A). The C-terminal 288 amino acids of C5041
contains five short signature segments, H-, N-, G1-, F-, and G2-
boxes, which are conserved across most histidine kinases [33,34].
The histidine residue within the H-box, which is very likely
phosphorylated during the signaling process, was found at position
394. In the N-terminal section of C5041, two transmembrane
helices were identified at position 15–35 and at position 297–317,
respectively. Between the two transmemebrane helices, a periplas-
mic domain, which might serve as a signal sensor, was identified
according to the distribution of charged residues ahead and behind
the postulated transmembrane helices. The periplasmic domain of
C5041 is 25.3% identical to that of DctB, a sensor kinase protein
for dicarboxylates transport in Sinorhizobium meliloti (of which
crystal structure is available) [35], suggesting C5041 may sense
analogs of succinate, which is sensed by DctB [36].
C5040 is 37% identical to the nitrogen regulatory protein C
(NtrC) [37,38] at the amino acid sequence level. C5040 harbors
the CheY-like receiver domain, phosphorylation site, AAA+
ATPase domain, and helix-turn-helix (HTH) domain (Fig. 1B).
The receiver domain (position 13–123) catalyzes phosphoryl
transfer from the HK to itself and regulates the output. The
aspartate residue, which is predicted to be phosphorylated in the
signal transduction cascade, was found at position 58. In the C-
terminal part of C5040, a helix-turn-helix domain was identified,
which is a DNA-binding domain that recognizes enhancer-like
sequences. The CheY-like receiver domain, AAA+ ATPase
Author Summary
Successful colonization requires bacterial pathogens to
adapt their metabolism to the conditions encountered in
particular infection sites. Two-component signaling sys-
tems (TCSs) enable bacterial pathogens to sense and
respond to environmental cues, thus mediating their
adaptation to environmental change. Though many TCSs
that have been characterized in commensal E. coli have
been associated with UPEC pathogenesis, no characterized
TCS has been significantly associated with UPEC strains.
Here, we characterized a UPEC-associated TCS that was
localized to a genomic island. This novel TCS and its target
genes were involved in anaerobic utilization of a-ketoglu-
tarate, an abundant metabolite in UPEC infection site-renal
proximal tubules, thus contributed to UPEC fitness in vivo.
Our results also suggest that this TCS controls a variant
tricarboxylic acid (TCA) cycle, the first described in E. coli,
which links the oxidative and reducing branches under
anaerobic conditions. Similar TCA branches have been
identified in other bacterial pathogens that have adapted
to oxygen-limited, obligate anaerobic conditions, and/or
intracellular carbon sources. Therefore, this study provides
new insight into the adaptation of bacterial pathogens to
nutrient availability in vivo and makes possible the
discovery of targets for antimicrobial treatment.
Novel TCS in UPEC pathogenesis
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domain, and helix-turn-helix (HTH) domains of C5040 are
32.5%, 51.7%, and 41.7% identical to that of NtrC, respectively.
Such characteristics are consistent with our expectations for a
TCS. Additionally, DNA sequence analyses were performed using
the search engine at http://blast.ncbi.nlm.nih.gov/Blast.cgi and
c5041 and c5040 did not show any homology to any characterized
histidine kinase or response regulator genes, suggesting that
C5041/C5040 is a novel TCS.
TCS genes c5041 and c5040 are significantly associated
with UPEC and increase CFT073 fitness in vivo
Sequence analysis of all E. coli genomes available online showed
that c5041/c5040 and its orthologs are absent from commensal
and diarrheagenic E. coli, but present in UPEC strains. Also,
genotyping of 317 E. coli clinical isolates including human
diarrheagenic E. coli and UPEC (Table S3) for c5041 and c5040
revealed their differential distribution. Both genes of this TCS
were amplified in 139 of 200 UPEC (69.5%) but were not detected
in 12 enterotoxigenic E. coli, 66 enterohemorrhagic E. coli or 39
enteropathogenic E. coli isolates. Therefore, c5041/c5040 appears
to be significantly associated with UPEC, raising the possibility
that C5041/C5040 contributes to UPEC fitness or virulence in
vivo.
To study the role of C5041/C5040 in UPEC fitness in vivo, we
compared the UPEC CFT073 wild-type strain with its Dc5041/
c5040 double deletion mutant strain for the ability to colonize the
mouse urinary tract at 48 hours post-inoculation using an in vivo
competition assay. The double deletion mutation was constructed
by replacement of c5041/c5040 with the cat cassette conferring
chloramphenicol resistance. Though Dc5041/c5040 mutants grew
as well as the wild type (WT) in LB, the mutant was significantly
outcompeted by the WT, with a nearly 10-fold reduction in the
median CFU/g from both bladders and kidneys at 48 hours post-
inoculation (Fig. 2A, P,0.05 for both organs). To verify that the
impact on colonization is not due to a secondary mutation, in vivo
complementation experiments were performed. A stable low-copy
plasmid pGEN-MCS was used as it was shown to be well
maintained in CFT073 up to 48 h even in the absence of
antibiotic pressure [39]. Coding regions of c5041 and c5040 plus
their predicted promoter region were cloned into pGEN-MCS,
and the resultant construct was named pc5041/c5040. As shown in
Fig. 2B and C, the Dc5041/c5040 mutant containing the empty
vector (pGEN-MCS) demonstrated an expected colonization
defect in bladder and kidneys colonization as compared to the
WT (empty vector) (P,0.05) while mutants harboring the
complementation plasmid (pc5041/c5040) were able to colonize
the bladder and kidneys at wild-type levels at 48 hours post-
inoculation. These results clearly demonstrate that c5041/c5040
has a role in UPEC colonization and fitness in vivo.
Proteomic determination of gene products targeted by
C5041/C5040
To determine how C5041/C5040 affects UPEC fitness in vivo,
2D-DIGE was used to identify differentially expressed gene
products in the proteomes of the WT and single deletion mutants
of c5041 and c5040 grown aerobically in human urine. Human
urine was used as the growth medium to simulate the urinary tract
environment [40–42]. c5041 and c5040 single mutants were
Figure 1. Predicted 3-D structures and conserved domains of the HK C5041 and the RR C5040. The exact positions of each domain are
described in the text. 3-D structures were predicted by I-TASSER online server. (A) HK C5041. The signature segments (H, N, G1, F, and G2) of the
kinase domain (CA, blue) and dimerization and histidine phosphorylation domain (DHp, yellow and purple) were identified by sequence alignment
and indicated. The conserved histidine residue is indicated by green. The two transmembrane helices (TMH-1 and TMH-2) were predicted by
transmembrane protein topology prediction tool TMMOD. (B) RR C5040. The receiver domain (yellow) containing the putative aspartate residue (Asp,
purple) for phosphorylation during signaling cascade, the AAA+ ATPase domain (blue), and the helix-turn-helix (HTH, red) domain for DNA binding
are shown.
doi:10.1371/journal.ppat.1003428.g001
Novel TCS in UPEC pathogenesis
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constructed by replacement with Chlr gene, and the resultant
mutants were named LMP100Chl (CFT073 Dc5041::Chlr) and
LMP101Chl (CFT073 Dc5040::Chlr). Using a cutoff of 1.5-fold
change, seventeen proteins in the mutants were differentially
expressed, as compared to the WT (Fig. S1). Of these, five were
induced and five were repressed in Dc5041::Chlr mutant; while six
were induced and five were repressed in the Dc5040::Chlr mutant.
To determine the identities of the differentially expressed proteins,
protein spots in the gel were excised and subjected to enzymatic
digestion with trypsin followed by tandem mass spectroscopy.
Functions of these proteins primarily fell into three categories:
metabolism, cell envelope constituents, and translational machin-
ery (Table 1). C5035, which showed a 24.6-fold induction, is a
putative 2-oxoglutarate dehydrogenase presumably involved in
tricarboxylic acid (TCA) cycle. XylA, a xylose isomerase, was
increased 8.7-fold. It catalyzes the interconversion between xylose
and xylulose. SitA, induced 4-fold, is a putative periplasmic iron-
binding protein. Several outer membrane proteins including
OmpA, NmpC, OmpF and OmpX were uniformly induced in
Dc5040::Chlr mutant. 50S ribosomal proteins, such as Rpll, RplQ,
and RplF, were also differentially expressed in the mutants as
compared to the WT. These results indicate that C5041/C5040
regulate multiple genes, suggesting that they may serve as a
pleiotropic two-component system.
Genomic island genes targeted by C5041/C5040
contribute to UPEC fitness in vivo
The most differentially expressed protein identified by proteo-
mic analysis was C5035, which was induced nearly 25-fold in the
Dc5041::Chlr mutant. qRT-PCR results confirmed that c5035 was
up-regulated in Dc5041::Chlr mutant, but not in Dc5040::Chlr
mutant, as compared to the WT when grown aerobically in
human urine (Fig. 3A). To rule out the possibility of polar effects,
the Chlr gene was removed from both Dc5041::Chlr and
Dc5040::Chlr mutants to generate mutants LMP100 (CFT073
Dc5041) and LMP101 (CFT073 Dc5040), respectively. Interest-
ingly, the expression of c5035 was detected at extremely low levels
not only in the mutant strains Dc5041 and Dc5040, but also in the
WT. No significant differences in the c5035 expression were
detected among the WT, Dc5041 and Dc5040 mutants when
grown in human urine under aerobic conditions (Fig. 3A). Note
that in the Dc5041::Chlr mutant, c5041 was replaced by the Chlr
gene, which transcribes in the same orientation as its downstream
gene, c5040. We further compared the expression levels of RR
c5040 in the WT, Dc5041, and Dc5041::Chlr mutants. The results
showed that expression of c5040 was extremely low in the WT and
Dc5041 mutant, but it was significantly upregulated in the
Dc5041::Chlr mutant when grown in human urine under aerobic
conditions (Fig. 3B). Therefore, we suspect that the upregulation of
c5035 in Dc5041::Chlr mutant was due to the constitutive
expression of c5040 caused by the upstream Chlr gene. If so,
overexpression of c5040 in the Dc5041 mutant should induce the
expression of c5035. Thus, c5040 was cloned into plasmid pMAL-
MCS under the control of promoter Ptac and the resultant plasmid
transformed into the Dc5041 mutant. Indeed, induction of c5040
significantly upregulated the expression of c5035 in the Dc5041
mutant (Fig. 3C). We also tested such regulation under different
culturing condition and the results revealed similar regulatory
pattern. In summary, constitutive expression of c5040 induced the
expression of c5035 regardless of growth conditions.
Further analysis of genomic localization of c5035 in CFT073
revealed that genes c5032-5039 including c5035, together with
TCS genes c5041 and c5040, are encoded by a genomic island
inserted between E. coli K12 genes tyrB and aphA (Fig. 4A). Not
surprisingly, island genes c5032-5039 were strongly associated with
UPEC, and about 91.4% of UPEC strains tested containing
c5040/c5041 loci also possess c5032-5039 genes (data not shown).
Prediction by bioinformatics tools (http://linux1.softberry.com/
berry.phtml and http://nostradamus.cs.rhul.ac.uk/,leo/
Figure 2. Deletion of c5041/c5040 reduces the colonization of the murine urinary tract by UPEC strain CFT073. (A) The WT and Dc5041/
c5040::Chlr mutant strains were mixed to a 1:1 ratio and approximately 26109 CFU were transurethrally inoculated into female mice. Two days after
infection, the mice were sacrificed and their bladders and kidneys were aseptically removed. WT and mutant bacteria were recovered by plating
homogenized tissue samples on LB or LB containing chloramphenicol and their viable counts were determined. (B) and (C), for the in vivo
complementation assay, a mixture of wild-type strain containing empty vector (e.v.) pGEN-MCS and mutant strain containing empty vector or wild-
type strain containing empty vector and mutant strain containing complementation plasmid (pc5041/c5040) were incolulated to female mice as in
(A). Homogenized tissue samples (B, bladder; C, kidneys) were plated on LB with ampicillin or LB with both ampicillin and chloramphenicol. Each dot
represents log10CFU/g in the bladder or kidney from an individual animal and the detection limit is 1000 CFU/g. Bars indicate the median log10CFU/g.
A two-tailed Wilcoxon matched pairs test was performed, and the difference in colonization levels of WT and mutants was considered statistically
significant if P,0.05.
doi:10.1371/journal.ppat.1003428.g002
Novel TCS in UPEC pathogenesis
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sak_demo/) followed by reverse transcription PCR indicate that
c5032-5037 forms one operon and c5038-5039 forms another (Fig.
S2).
We then examined if this genomic island contributed to UEPC
fitness in vivo. An in vivo competition assay was used to compare the
colonization levels of Dc5032-5039 mutants with that of wild-type
strain. Dc5032-5039 mutant was constructed by replacement with
the cat cassette. Fig. 4B showed that there is significant reduction in
colonization levels of Dc5032-5039mutants in bladder and kidneys
at 48 hours post-inoculation, as compared to the WT (P,0.05).
These results clearly demonstrated that island genes c5032-5039
are involved in UPEC colonization of murine urinary tract and it’s
tempting to presume that C5041/C5040 contributes to UPEC
fitness through regulation of c5032-5039 genes (The results that all
other target genes in the genomic island are regulated by TCS
C5041/C5040 were shown later in this paper).
Island genes c5032-5039 contribute to anaerobic a-KG
utilization and a-KG induces their expression under
anaerobic conditions
The proteins encoded by c5032, c5034, and c5035 are
homologous to the E1, E2 and E3 components of a-KG
dehydrogenase in E. coli, with similarity of 64%, 69%, and 55%,
respectively; whereas, the proteins encoded by c5036 and c5037
are 70% and 83% similar to the beta- and alpha-subunits of
succinyl-CoA synthetase from E. coli. a-KG dehydrogenase
converts a-KG to succinyl-CoA, which can be further transformed
to succinate by succinyl-CoA synthetase [43]. c5038 is predicted to
encode a putative dicarboxylate transporter with 13 transmem-
brane alpha-helices (TMHMM program [44]), showing 49%
similarity to citrate/succinate antiporter CitT, and c5039 encodes
an enzyme belonging to malate/L-lactate dehydrogenase (Ldh_2)
family. To test the hypothesis that these enzymes and the
metabolic transporter are involved in a-KG utilization, we
compared the growth of the WT, the Dc5032-5037 mutant, the
Dc5038-5039 mutant, and the Dc5032-5039 mutant in M9
minimal medium with a-KG as the sole carbon source. Under
aerobic conditions, no significant growth differences were
observed among these strains (Fig. S3). However, when tested
under anaerobic conditions, deletion of c5032-5039 completely
abolished the growth, and the Dc5032-5037 and Dc5038-5039
mutants also displayed statistically significant growth defects, as
compared to the WT (Fig. 5A). We further tested their growth in
M9 medium containing glucose, glycerol, or four-carbon dicar-
boxylate compounds, including succinate, fumarate, and malate,
as the sole carbon source. In these cases, no differences were found
Table 1. Differentially expressed proteins identified in mutant strains of UPEC CFT073 as compared to the wild-type when
cultured in human urine.
Order Name or ORF Function MWa/pIb
No. of
peptides
matched
Total
ion
score
Total ion
C.I.c %
Fold-
Changed
Differentially expressed proteins in Dc5041::Chlr mutant
1 C5035 putative 2-oxoglutarate dehydrogenase 49832/6.1 16 172 100 24.6
2 XylA xylose isomerase 49634/5.63 16 63 100 8.7
3 SitA putative periplasmic iron-binding protein 31544/8.7 12 284 100 4.0
4 TufB EF-Tu 43427/5.3 7 556 .95 2.2
5 GlnA glutamine synthetase 52099/5.26 2 76 .95 2.0
6 YbiS hypothetical protein 33059/5.99 10 232 100 21.9
7 SpeE spermidine synthase 32286/5.33 7 228 100 22.2
8 RplF 50S ribosomal protein L6 17763/9.49 9 208 100 22.2
9 RplQ 50S ribosomal protein L17 14355/11.05 6 115 100 23.2
10 RplI 50S ribosomal protein L9 15759/6.17 14 474 100 24.0
Differentially expressed proteins in Dc5040::Chlr mutant
1 OmpA outer membrane protein A precursor 41028/6.24 17 449 100 4.2
2 OmpA outer membrane protein A precursor 41028/6.24 14 317 100 3.0
3 NmpC outer membrane porin protein nmpC precursor 40277/4.64 6 391 .95 2.1
4 OmpF outer membrane protein F precursor 39309/4.76 9 496 .95 1.9
5 OmpX outer membrane protein X precursor 18648/6.56 2 152 .95 1.9
6 RplF 50S ribosomal protein L6 18949/9.71 7 356 .95 1.8
7 RplD 50S ribosomal protein L4 22073/9.72 5 380 .95 21.9
8 FocD F1C fimbrial usher 96379/6.72 1 29 .95 21.9
9 Tig Trigger protein 48163/4.83 4 150 .95 22.0
10 TufB EF-Tu 43427/5.3 11 677 .95 22.3
11 RplQ 50S ribosomal protein L17 14355/11.05 5 211 100 24.3
aMolecular weight.
bIsoelectric point.
cConfidence interval (Ion Confidence Interval % greater than 95 were considered significant).
dAverage from two biological repeats.
doi:10.1371/journal.ppat.1003428.t001
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among the strains tested (data not shown). These results indicated
that genomic island genes c5032-5039 specifically contribute to a-
KG utilization under anaerobic conditions but play no or a very
limited role in a-KG utilization under aerobic conditions.
The ability of a-KG to induce expression of c5032-5039 was also
examined. Chromosomal c5032-lacZ and c5038-lacZ transcriptional
reporter fusions in CFT073DlacZYA were constructed in order to
study the expression of operon c5032-5037 and operon c5038-5039,
and b-galactosidase activity in M9 medium using a-KG (40 mM) as
the sole carbon source was also determined. Under anaerobic
conditions, a-KG significantly induced the expression of c5032 and
c5038, as compared to the rich medium LB or M9 medium
containing glycerol or glucose as the sole carbon source (Fig. 5B);
while the analogs of a-KG such as 2-HO-glutarate, glutamate,
glutarate, fumarate, or succinate could not. To verify that other target
genes on the genomic island are also induced by a-KG, qRT-PCR
was performed. RNA was isolated from bacteria grown in M9
medium (glycerol and TMAO) with or without inducer a-KG. As
shown in Fig. S4, all of the genes tested were greatly induced in the
presence of a-KG. We then examined the effect of a-KG
concentration on the stimulation of c5038 expression. Bacteria were
grown in M9 medium plus glycerol and TMAO in the presence of
various amounts of a-KG. We found that the induction of c5038 by
the presence of a-KG was dose-dependent with concentrations as low
as 200 mMable to induce their expression under anaerobic conditions
(Fig. 5C). These results indicate that island genes c5032-5039 are
induced by a-KG and involved in anaerobic utilization of a-KG.
C5040 directly regulates the expression of c5032-5039 and
contributes to a-KG utilization under anaerobic conditions
To determine the regulatory role of C5040 in a-KG induction
of target genes, chromosomal c5032-lacZ and c5038-lacZ tran-
scriptional reporter fusions in the Dc5040 mutant were construct-
ed. Strains were grown in M9 medium containing glycerol and
TMAO in the presence or absence of inducer a-KG under
anaerobic conditions. As shown in Fig. 6A, in wild-type genetic
background, c5032 and c5038 expression was considerably
induced in response to a-KG; in contrast, deletion of c5040
abolished the expression of c5032 and c5038 to the background
level under anaerobic conditions. Re-introduction of a plasmid
construct pc5041/c5040 carrying c5041/c5040 genes with their
native promoter into c5040 mutants (LMP206 and LMP209)
markedly increased expression of c5032 and c5038; whereas, the
empty plasmid vector did not affect the expression of c5032 and
c5038. In addition, the regulation of other target genes (c5034,
c5035, c5036, c5037, and c5039) in the genomic island in response
to a-KG by C5040 was confirmed using qRT-PCR (Fig. S4).
Together, these results indicate that a-KG induction of c5032-
5039 is C5040-dependent (Fig. 6A).
To determine if C5040 directly regulates c5032 and c5038
expression, an electrophoretic mobility shift assay (EMSA) was
performed. The promoter regions of c5032 and c5038 were
predicted by BProm program (http://linux1.softberry.com) [45].
The potential binding sites for c5032 and c5038 were identified
and found to be highly similar, with TGTGTG-N13-CGCGCA
for c5032 and TGTGCG-N8-CGCACA for c5038. DNA frag-
ments containing the potential binding sites were then PCR
amplified for use as probes (305 nucleotides in size for c5032,
starting from2272 to +32 relative to translational start codon; 196
nucleotides in size for c5038, starting from 2163 to +32 relative to
translational start codon). Fragments amplified from the coding
region of c5036 were used as negative controls. Gene c5040
encoding the RR was cloned into the expression vector pMal-c2x
and fused with MBP-His6. MBP-C5040-His6 fusion protein
retained its regulatory biological function since introduction of
Figure 3. Overexpression of c5040 upregulated c5035 expression independent of the natural stimulus. Bacteria were grown in human
urine under aerobic conditions before being subjected to RNA extraction. qRT-PCR expression values are means plus standard deviations (error bars)
of three independent experiments. (A) c5035 expression in various TCS mutants compared to WT. (B) c5040 expression in Dc5041 and Dc5041::Chlr
mutants compared to WT. (C) c5035 expression in Dc5041 mutant carrying the pMAL plasmid with c5040 under the control of Ptac promoter as
compared to Dc5041 mutant carrying the empty vector (e.v.). IPTG is present at 1 mM for induction.
doi:10.1371/journal.ppat.1003428.g003
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the plasmid construct expressing MBP-C5040-His6 fusion protein
into Dc5040 mutant activated the expression of c5038; whereas,
the empty plasmid did not affect expression of c5038 (Fig. S5). As
shown in Fig. 6B, the purified MBP-C5040-His6 fusion protein
was able to shift the promoter fragments of both c5032 and c5038,
but not the control fragment. Meanwhile, use of the purified MBP-
His6 fusion protein without C5040 was not associated with a
detectable protein-DNA complex (Fig. 6B). These results demon-
strate that C5040 directly binds to the promoters of the two
operons.
To determine if C5040 is involved in the utilization of a-KG as
the sole carbon source under anaerobic conditions, the growth
properties of the WT, Dc5040 mutants, and the complemented
strains were compared. When grown in M9 medium with a-KG as
the sole carbon source under anaerobic conditions, the Dc5040
mutant strains showed a growth defect as compared to the WT.
The c5040-complemented strain (Dc5040 carrying pc5041/c5040)
significantly increased growth in this medium; while the empty
plasmid vector (pGEN-MCS) did not improve growth of the
mutant (Dc5040) (Fig. 6C).
The role of C5041 in the expression of island genes
c5032-5039
The regulatory role of HK C5041 was also determined.
Chromosomal c5032-lacZ and c5038-lacZ transcriptional reporter
fusions in the Dc5041 mutant (LMP106) were obtained to create
LMP205 and LMP208, respectively. Strains were grown in M9
medium (supplemented with glycerol and TMAO) with or without
inducer a-KG under anaerobic conditions. Deletion of c5041
abolished the expression of c5032 and c5038 to background levels
in the presence of a-KG. Re-introduction of the plasmid pc5041
carrying the c5041 gene with its native promoter into LMP205 and
LMP208 mutants significantly increased their expression
(P,0.05), indicating that C5041 positively affects expression of
the target genes (Fig. 7A). This suggests that phosphorylation is
very important for the regulatory function of RR C5040. In
Figure 4. c5032-5039 genes are located on a genomic island and contribute to UPEC fitness in vivo. (A) Similar genomic regions of E. coli
K12 strain MG1655, EHEC strain EDL933, and UPEC strain CFT073 were compared and it was found that c5032 to c5041 genes are inserted between
tyrB and aphA genes and can be considered as a genomic island. Within the island, three predicted operons shown as white, grey, and black arrows,
respectively. Picture was drawn to scale. UPEC, uropathogenic E. coli; EHEC, enterohemorrhagic E. coli. (B) Island genes c5032-5039 contribute to UPEC
fitness in vivo. An in vivo competition assay was used. Equally mixed WT and Dc5032-5039::Chlr mutant bacteria containing approximately 26109 CFU
were transurethrally inoculated into female mice. Two days after infection, the mice were sacrificed and their bladders and kidneys were aseptically
removed. Wild-type and mutant bacteria were recovered by plating homogenized tissue samples on LB or LB containing chloramphenicol and their
viable counts were determined. Each dot represents log10CFU/g in the bladder or kidney from an individual animal and the detection limit is
1000 CFU/g. Bars indicate the median log10CFU/g. A two-tailed Wilcoxon matched pairs test was performed, and the difference in colonization levels
of WT and mutants was considered statistically significant if P,0.05.
doi:10.1371/journal.ppat.1003428.g004
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addition, the expression of other genes (c5034, c5035, c5036,
c5037, and c5039) in the genomic island affected by C5041 was
also confirmed using qRT-PCR (Fig. S4). The growth phenotypes
of the c5041 mutant and its complementation strain in difference
medium were then tested. Interestingly, the growth of the WT and
its derivative mutants (c5041 mutant and complementation strain)
in all media tested was statistically indistinguishable (Fig. 7B).
Oxygen tension modulates expression of c5032-5037 and
c5038-5039 directly via the TCS C5041/C5040
Island genes c5032-5039 contribute to anaerobic utilization of
a-KG but play a limited role under aerobic conditions causing us
to suspect that oxygen might modulate expression of these genes.
Indeed, the c5032-5037 operon encoding a putative a-KG
dehydrogenase and a putative succinyl-CoA synthetase was
upregulated .5-fold in a reduced oxygen environment. Similarly,
the expression of the c5038-5039 operon, encoding a putative
transporter of a-KG and a protein with unknown function, was
upregulated 2-fold under anaerobic conditions, as compared to
aerobic conditions (Fig. 8A).
To determine if oxygen regulates c5032-5039 expression via
C5041/C5040 but not through other independent pathways, the
effects of c5041/c5040 double deletion on the expression of c5032-
5039 were examined. Deletion of c5041/c5040 completely
abolished expression of the two operons under both aerobic and
anaerobic conditions, supporting the hypothesis that oxygen
regulates these two operons via TCS C5041/C5040 (Fig. 8A).
In addition, we wished to determine if oxygen deficiency
regulates expression of the TCS itself. Under anaerobic conditions,
the expression of c5041 was about 3-fold greater than that
observed under aerobic conditions (Fig. 8B), suggesting that c5041
expression is significantly induced in response to anaerobiosis.
Similarly, under anaerobic conditions, c5040 expression is
dramatically increased as compared to that under aerobic
conditions (Fig. 8B). These results suggested that oxygen deficiency
upregulated the expression of c5041 and c5040 and raised the
possibility that oxygen modulates the expression of c5032-5037
and c5038-5039 operons via controlling c5041/c5040 expression.
However, these results did not rule out the possibility that
anaerobiosis stimulates the typical TCS phosphotransfer reactions
between C5041 and C5040, leading to increased DNA binding
and up-regulation of target gene expression.
Discussion
One of the greatest challenges confronted by all microorganisms
is adapting to rapid changes of nutrient availability in different
habitats. In the course of evolution, bacteria have developed
several mechanisms to sense and utilize available nutrient sources
associated with particular niches or to favor the most efficiently
metabolizable nutrient sources when exposed to a range of
Figure 5. Contribution of c5032-5039 to growth on a-KG and induction of c5032-lacZ or c5038-lacZ expression by a-KG. (A) In vitro
growth of island gene mutants in M9 medium containing a-KG as the sole carbon and energy source. Optical density of the CFT073 WT and mutants
during growth in M9 medium containing a-KG as the sole carbon source under anaerobic conditions was determined. Growth bars represent the
average measurement at each time point from triplicate experiments. (B) Effects of different substrates on c5032-lacZ or c5038-lacZ expression. Gluc,
glucose; Glyc, glycerol; TMAO, Trimethylamine N-oxide. (C) The induction of c5038-lacZ expression by a-KG is dose-dependent. Bacteria were grown in
M9 medium containing 0.25% glycerol as the sole carbon source plus different amounts of a-KG as stimulus under anaerobic conditions.
doi:10.1371/journal.ppat.1003428.g005
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choices. TCSs are major mechanisms enabling bacteria to couple
environmental stimuli to adaptive responses [46]. The TCSs in E.
coli K12 have been extensively studied [25–27]. Many TCSs that
are common to both commensal and pathogenic E. coli, such as
PhoQ/PhoP [31], QseC/QseB [29,30], BarA/UvrY [28], and the
AirS system [32] have been shown to contribute to virulence by
mediating bacterial adaption to the host environment. However,
no pathogen-associated TCS has yet been characterized in E. coli.
Driven by the hypothesis that UPEC-associated TCSs exist to
sense and respond to host environment signals distinct from those
Figure 6. The role of c5040. (A) Effects of c5040 on the expression of target genes in response to a-KG. Bacteria were anaerobically grown in M9
medium containing glycerol as sole carbon source and TMAO as electron acceptor in the absence or presence of a-KG. The expression of c5032-lacZ
or c5038-lacZ in WT, Dc5040 (LMP107), and the complemented strains were represented by the b-galactosidase activity. (B) Non-radioactive EMSA
studying the binding of MBP-C5040-His6 to the promoter regions. PCR products of c5032 promoter region (left panel) and c5038 promoter region
(right panel) were used as probes. Purified MBP-C5040-His6 fusion protein was added in different concentration in each reaction mixture as indicated
and MBP-His6 was used as negative control at 300 ng per each reaction. For the lane on the right on each panel, a negative control DNA fragment
amplified from coding region of c5036 was used. DNA fragments were stained with SYBR green. (C) In vitro growth of Dc5040mutants. Optical density
of the CFT073 WT, Dc5040 mutant, and the complemented strain during growth in M9 medium containing a-KG as the sole carbon source under
anaerobic conditions was measured. Growth bars represent the average measurement at each time point from triplicate experiments.
doi:10.1371/journal.ppat.1003428.g006
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of intestinal E. coli, we identified a novel TCS C5041/C5040
significantly associated with UPEC strains, but not with EHEC,
EPEC or ETEC strains. This TCS activated the expression of a
genomic island involved in transport and metabolism of a-KG
under anaerobic conditions. In view of these findings, C5041 was
renamed KguS (a-ketoglutarate utilization sensor) and C5040
renamed KguR (a-ketoglutarate utilization regulator). These
results indicated that UPEC might actively import a-KG and
that a-KG could be an important carbon source for UPEC in vivo.
Consistent with this observation, deletion of the TCS or its target
island genes resulted in a significant reduction in a UPEC’s
colonization of the murine urinary tract. To our knowledge, this is
the first report of a pathogen-associated TCS in E. coli that
contributes to UPEC pathogenesis.
a-KG is an intermediate in the citric acid/tricarboxylic acid
(TCA) cycle, which is a metabolic pivot for both catabolic and
anabolic processes that supply key metabolic intermediates and
energy in most eubacteria [47]. Many intermediates in the TCA
cycle can be sensed by TCSs, which elicit an adaptive response in
E. coli. Four-carbon (C4) dicarboxylate-sensing DcuS/DcuR was
shown to control fumarate transportation (dcuB) and respiration
(frdABCD) under anaerobic conditions, and under aerobic condi-
Figure 7. The role of c5041. (A) Effects of c5041 on the expression of the target genes in response to a-KG. The expression of c5032-lacZ or c5038-
lacZ in the WT, Dc5041 (LMP106), and the complemented strains were represented by the b-galactosidase activity. (B) In vitro growth of Dc5041
mutants. Optical density of CFT073 WT, Dc5041 mutant, and the complemented strain during growth in M9 medium containing a-KG as the sole
carbon source under anaerobic conditions was measured. Growth bars represent the average measurement at each time point from triplicate
experiments.
doi:10.1371/journal.ppat.1003428.g007
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tions affect the utilization of most of C4-dicarboxylates like
succinate, fumarate, malate, and aspartate [48,49]. In addition,
tricarboxylate-sensing CitA/CitB was demonstrated to regulate
anaerobic citrate fermentation genes citCDEFXGT encoding an
active holo-citrate lyase catalyzing the breakdown of citrate to
acetate and oxaloacetate and a citrate carrier [50–52]. This study
has demonstrated that a novel TCS KguS/KguR responds to and
only to a-KG, a five-carbon (C5) dicarboxylate by activating
metabolic enzymes and transporter involved in anaerobic metab-
olism of a-KG. This is the first-time that such a TCS has been
identified responding to C5-dicarboxylate in E. coli. Identification
of the TCS regulating utilization of C4, C5-dicarboxylates and
tricarboxylate suggested the tight control of the pathways involved
in the metabolism of intermediates in E. coli TCA cycle.
As found in this study, a-KG can induce expression of the TCS
target genes c5032-5039, while deletion of kguS or kguR abolished
their expression in response to a-KG. By extrapolation from what
we know of other TCSs and the results obtained in this study, it is
very likely that a-KG serves as the signal molecule and HK KguS
senses it via its periplasmic domain, then phosphorylates itself, and
subsequently trans-phosphorylates KguR, which can then induce
expression of the target genes. Very interestingly, overexpression
of KguR can activate the expression of target genes independent of
inducer a-KG. Similar observations have been reported for
Salmonella where induction of target genes depends on the
intracellular concentration of the response regulator PhoP and
overexpression can substitute for phosphorylation and enhance the
functionality of PhoP [53]. We further confirmed that oxygen
tension modulated the expression of this pathway by regulating the
expression of KguS/KguR itself. In E. coli, regulation by oxygen is
usually mediated by the cytoplasmic regulator FNR and/or by
TCS ArcB/A [54]. Currently, it is unknown if FNR and/or ArcB/
A have any effect on the expression of KguS/KguR.
Genome sequencing has shown that the TCA cycle is a readily
modified pathway in bacteria with many strains harboring variant
TCA cycles. The common feature of these variants is the absence
or repression of the a-KG dehydrogenase with the oxidative
branch terminating in the production of a-KG and the reducing
branch in succinate [55,56]. Like any other E. coli, UPEC operate
a complete TCA cycle aerobically, but the a-KG dehydrogenase
shared by all E. coli is neither functional nor expressed under
anaerobic conditions [47]. The KguS/KguR-controlled metabolic
pathway in UPEC includes a putative a-KG dehydrogenase
(c5032-5035) and a putative succinyl-CoA synthetase (c5036-5037),
which were induced and contributed to utilization of a-KG under
anaerobic conditions. To our knowledge, this is the first variant
TCA cycle described in E. coli that links the oxidative and reducing
branches under anaerobic conditions. To maintain carbon flux
under oxygen-limiting or anaerobic conditions, many microaero-
philic and obligate anaerobic organisms that lack a-KG dehydro-
genase possess similar bypass pathways to metabolically link
oxidative and reducing branches. Helicobacter pylori preferably
growing under microaerophilic conditions use a-KG ferredoxin
oxidoreductase to connect oxidative and reducing half-cycles [57].
Likewise, in Mycobacterium an a-KG decarboxylase structurally
related to the E1 component of 2-oxoglutarate dehydrogenase can
produce succinic semialdehyde (SSA), which is subsequently
oxidized to succinate by succinic semialdehyde dehydrogenase
(SSADH) [58]. This study and other groups’ findings have
highlighted the importance of the branched variants in adaptation
to oxygen limiting or obligate anaerobic conditions and suggest
that UPEC have different metabolic niches and needs compared
to other E. coli.
The acquisition of additional metabolic traits often increases
adaptability and competitiveness of pathogens in a new niche
[18,22]. This study found that TCS KguS/KguR and its
controlled-anaerobic utilization pathway of a-KG were encoded
by a genomic island in UPEC, which was absent from the genomes
of commensal E. coli and intestinal pathogenic E. coli. These results
were consistent with the previous report that c5032 to c5040 were
among the 131 UPEC-specific genes identified using comparative
genomic hybridization and in silico analysis of ten UPEC and four
fecal/commensal isolates [59], and also suggested that this
genomic island may facilitate UPEC’s adaptation to in vivo
colonization. This was confirmed by the observation that deletion
of kguS/kguR resulted in a significant reduction in UPEC
Figure 8. Oxygen tension modulates the expression of two operons in genomic island via TCS C5041/C5040. (A) Target genes’
expression in c5041/c5040 mutants under aerobic and anaerobic conditions. The expression of c5032-lacZ or c5038-lacZ in WT and Dc5041/c5040
mutant (LMP108) under aerobic and anaerobic conditions were compared. (B) Induction of c5041/c5040 expression by oxygen deficiency. c5041-lacZ
and c5040-lacZ transcriptional fusion strains were grown in M9 medium containing a-KG as the sole carbon source under aerobic and anaerobic
conditions, respectively. b-galactosidase activity was measured and the values shown are means plus standard deviations of triplicate samples.
doi:10.1371/journal.ppat.1003428.g008
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colonization in the bladders and kidneys of mice. However,
deletion of kguS/kguR or its target genomic island genes did not
affect growth in human urine in vitro under both aerobic and
anaerobic conditions (data not shown). We reasoned that human
urine might only be able to partially imitate the in vivo conditions of
UPEC infection, whereas the contributions of KguS/KguR to
UPEC pathogenesis may be restricted to some particular site of
infection or pathogenic process, which cannot be represented by
urine.
Interestingly, Chlamydia trachomatis, an obligate intracellular
bacterial pathogen of urogenital infections [60], possesses an
incomplete TCA cycle. Because of their small genome,
chlamydiae lack many metabolic pathways retaining only the
functions for performing key steps and interconversions of
metabolites from the host cells. The fact that chlamydiae lack
the first three enzymes of the TCA pathway and obtains a-KG
from their host cell via a membrane transporter [56,61] suggests
that utilization of intracellular a-KG is important for the survival
of this urogenital intracellular pathogen. It could be inferred from
Chlamydia and hypothesized that a-KG might be one of the
preferred carbon and energy sources for UPEC during infection.
Previous studies supporting this hypothesis showed that the
oxygen tension (PO2) in UPEC-infected tissue dropped to
0 mmHg within 3.5–4 h [62], suggesting UPEC encountered
anaerobic conditions during infection. It was also reported that
the concentration of a-KG in human cells and blood is about
10 mM, a concentration that was able to induce the expression of
KguS/KguR-controlled pathway in vitro under anaerobic condi-
tions in this study. The KguS/KguR-controlled transporter
(C5038) differs from the constitutively expressed KgtP encoded
by all E. coli [63,64] and was induced under anaerobic conditions.
During infection, this transporter allows UPEC to import a-KG
from the infected tissue into the cell, and a-KG dehydrogenase
and succinyl-CoA synthetase allow UPEC to take advantage of a-
KG under anaerobic conditions, thus contributing to UPEC’s in
vivo fitness. More interestingly, proximal tubule cells in the kidney
are able to accumulate a-KG. Proximal tubules are the primary
site where organic anions (OA) of physiological, pharmacological,
and toxicological importance are cleared from the body. Their
clearance involves uptake of OA via OA-dicarboxylate exchange
driven by a-KG gradients. Thus, intracellular concentration of a-
KG in the proximal tubule cells is ,100–400 mM, which is 10 to
40-fold higher than that found in any other cells [65–67]. UPEC
undergo an intracellular lifestyle where they form biofilm-like
communities [68], and UPEC are able to infect proximal tubule
cells [62,69–71]. However, very little is known about the
metabolism of UPEC within these host cells. It is very likely
that KguS/KguR-controlled anaerobic utilization pathway of a-
KG would increase UPEC fitnessduring infections of renal
proximal tubule cells. Future studies in our laboratory should
help clarify these questions.
In summary, our findings suggested a model that describes a
novel regulatory and metabolic pathway in UPEC. For optimal
growth during infection, HK KguS may sense a-KG, an abundant
metabolite in UPEC infection site-renal proximal tubules, and
then phosphorylate the RR KguR, which finally activates the
import and utilization of a-KG (Fig. 9). These findings provide
compelling evidence that this first UPEC-associated TCS enables
E. coli to sense infection niche-specific stimuli and adapt to local
nutrient availability, thus increasing its in vivo fitness. Hopefully,
this and future studies on this regulatory system and metabolism
pathway could lead to a better understanding of correlations
between bacterial metabolism and virulence, but also the
molecular pathogenesis of UPEC.
Materials and Methods
Ethics statement
7All animal procedures were conducted in accordance with
NIH guidelines, the Animal Welfare Act and US federal law. The
experimental protocol (Protocol number 4-11-7111-Z) for han-
dling animals was approved by Institutional Animal Care and Use
Committee at Iowa State University (IACUC). All surgery was
performed under isoflurane anesthesia, and all efforts were made
to minimize suffering.
The study using human urine was approved by Institutional
Review Board (IRB ID: 04-171). Written informed consent was
obtained from human participants and/or their legal guardians for
urine collection.
Bacterial strains and culture conditions
Strains and plasmids used in this study are listed in Table S1.
Aerobic growth was achieved by shaking in air at 180 rpm and
anaerobic growth by incubating in a Bactron chamber (Sheldon
Manufacturing, Inc., OR) filled with gas mixture (N2, 90%; CO2,
5%; H2, 5%). For genetic manipulations, all E. coli strains were grown
routinely in lysogenic broth (LB) medium. For growth and gene
expression studies, bacteria were generally grown aerobically or
anaerobically in M9 minimal salts with certain carbon sources
indicated, supplemented with 2 mM MgSO4, 0.1 mM CaCl2, and
1 mg/ml vitamin B1. When used, trimethylamine N oxide (TMAO)
and di- or tri-carboxylates were present at 40 mM. Glucose (0.5% v/
v) or glycerol (0.25% v/v) was added as energy substrates, as
indicated. Fresh mid-stream human urine was collected from sixmale
and female consenting donors, pooled, and filter sterilized. Selective
antibiotics and IPTG were added when necessary at the following
concentrations: ampicillin (Amp), 100 mg ml21; kanamycin (Kan),
50 mg ml21;chloramphenicol (Chl), 25 mg ml21; IPTG, 1 mM.
Recombinant DNA techniques
Polymerase chain reaction (PCR), DNA ligation, electroporation
andDNA gel electrophoresis were performed according to Sambrook
and Russel [72] unless otherwise indicated. All oligonucleotide
primers were purchased from Integrated DNA Technologies (Iowa)
and are listed in Table S2. All restriction and DNA-modifying
enzymes were purchased from New England Biolabs and used based
on the suppliers’ recommendations. Recombinant plasmids, PCR
products, and restriction fragments were purified using QIAquick
PCR purification kit or MinElute gel extraction kit (Qiagen, CA) as
recommended by the supplier. DNA sequencing was performed at
the DNA facility, Iowa State University. DNA and amino acid
sequence analyses were performed using CloneManager software
(Scientific & Educational Software, NC) and the search engine
(http://blast.ncbi.nlm.nih.gov/Blast.cgi.) was used to identify con-
served domain structures of the two-component system.
Deletion mutants were constructed using the lambda red
recombinase system described by Datsenko and Wanner [73].
Chromosomal transcriptional lacZ fusion was constructed by homol-
ogous recombination of the suicidal plasmid pVIK112 carrying a
fragment of complete 59-region, 39- region, or internal fragment of the
target gene [74]. Briefly, PCR fragments of target genes were cloned
into pVIK112 using EcoRI and XbaI sites. The resultant pVIK112
derivatives were introduced into CFT073DlacZYA::Chlr by conjugation
and the integration was allowed to occur. Conjugants were selected
and confirmed by PCR. Chlr was removed by transforming pCP20
plasmid carrying flippase [75]. For complementation, the coding
sequences of genes plus their putative promoter regions were amplified
from the CFT073 genome and independently cloned into pGEN-
MCS [39] using EcoRI and SalI restriction sites.
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To construct the plasmid overproducing MBP-KguR-His6
fusion protein, a 1.4-kb fragment containing the coding region
of kguR was obtained by PCR from genomic DNA using MalE/
c5040Histag-F and MalE/c5040Histag-R carrying codons for
66His and subsequently cloned into pMAL-c2x (New England
Biolabs) using BamHI and HindIII sites. The resultant plasmid
contains MBP-KguR-His6 under the control of the Ptac promoter.
The construction of control vector pMAL-MCS was achieved by
replacing the MalE coding sequence with the MCS fragment from
pEGFP plamid using NdeI and EcoRI sites.
PCR genotyping
The nucleotide sequences publicly available of c5041/c5040
genes were aligned by using the ClustalW2 program. The primers
were selected from a relatively conserved region and on the basis
of G/C content, annealing temperature and size of the amplicon.
Multiplex PCR was carried out according to Johnson et al. [76].
b-Galactosidase assays
Overnight LB cultures of E. coli containing the gene of interest-lacZ
fusions were washed with PBS once and then were diluted 1:100 in
LB or M9 medium with the carbon sources indicated and grown at
37uC to log phase. These cultures were diluted 1:10 in Z buffer and
assayed for b-galactosidase activity using ortho-Nitrophenyl-b-
galactoside (ONPG) as a substrate as described previously [77].
2D-DIGE
To prepare bacterial protein samples, isolated colonies were
used to inoculate LB and cultures grown overnight at 37uC, the
culture was further diluted 1:50 to fresh LB medium and re-
incubated; after OD 600 reached 1.0, 2 ml of culture (approxi-
mately 109 CFU) was pelleted and the supernatant removed.
Bacterial pellets were re-suspended in 20 ml of human urine and
grown aerobically for 4 hours at 37uC. Bacteria grown in human
urine were then collected by centrifugation and washed 3 times
with sterile PBS. The resultant bacterial pellets were snap-frozen at
280uC and submitted to Applied Biomics, Inc. in California for
Fluorescence difference in gel electrophoresis (2D-DIGE) [78].
Reverse transcription PCR and quantitative real-time RT-
PCR
RNA from E. coli CFT073 and its derivatives was stabilized by
RNAprotect Bacterial Reagent (QIAGEN) and extracted using an
RNeasy Mini Kit (QIAGEN) with a one-hour in-tube DNase
digestion (QIAGEN) to remove possible DNA contamination
according to the manufacturer’s instructions. Three biological
replicates of the each sample were prepared. The concentration of
RNA was determined using a Spectrophotometer (ND-1000)
(NanoDrop).
For the co-transcription test, one microgram of total RNA was
reverse transcribed in triplicate using random hexamers and
ImProm-II reverse transcriptase (Promega). Reactions without
reverse transcriptase were used as a DNA contamination control.
cDNA was then used as template for subsequent PCR reactions.
For quantitative real-time RT-PCR, melting curve analyses
were performed after each reaction to ensure amplification
specificity. Differences (n-fold) in transcripts were calculated using
the relative comparison method, and amplification efficacies of
each primer set were verified as described by Schmittgen et al
[79]. RNA levels were normalized using the housekeeping gene tus
Figure 9. A schematic model for the regulatory mechanism of C5041/C5040 and its controlled target genes. In certain host
environments of UPEC, such as the epithelial cells of renal proximal tubule, where oxygen tension is low and a-KG is abundant, KguS/KguR can sense
and respond to these stimuli by activating the expression of c5038 encoding dicarboxylate transporter and c5032-5037 genes encoding metabolic
enzymes, involved in the utilization of a-KG as carbon and energy source. Possession and functionality of this system may meet special metabolic
needs for UPEC during urinary tract infections. Question mark indicates function is unknown. Blue dots, a-KG (a-ketoglutarate); Succ-CoA, succinyl-
CoA; Succ, succinate.
doi:10.1371/journal.ppat.1003428.g009
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encoding DNA replication terminus site-binding protein as an
endogenous control [80]. Quantitative real-time RT-PCR (qRT-
PCR) was performed with a Bio-Rad iQ5 iCycler detection system
using iScript one-step RT-PCR kit with SYBR Green (Bio-Rad)
according to the manufacture’s instruction [81].
Electrophoretic mobility shift assays
To study the binding of KguR to the DNA probe, electropho-
retic mobility shift assays (EMSAs) were performed using the
commercialized EMSA kit (Invitrogen, California) [82].
MBP-KguR-His6 fusion protein was purified to homogeneity
using Ni-NTA Spin Columns and dialyzed against binding buffer.
DNA probes were PCR amplified using specific primers and gel
purified using a QIAGEN MinElute gel extraction kit. EMSAs
were performed by adding increasing amounts of purified MBP-
KguR-His6 fusion protein (0 to 300 ng) to the DNA probe (60 ng)
in binding buffer (10 mM Tris (pH 7.5), 1 mM EDTA, 1 mM
dithiothreitol, 50 mM KCl, 50 mM MgCl2, 1 mg ml
21 bovine
serum albumin (NEB)) for 30 min at room temperature. Reaction
mixtures were then subjected to electrophoresis on a 6%
polyacrylamide gel in 0.56TBE buffer (44.5 mM Tris, 44.5 mM
boric acid, 1 mM EDTA, pH 8.0) at 200 V for 45 min. The gel
was stained in 0.56TBE buffer containing 16SYBR Gold nucleic
acid staining solution for 30 min.
Experimental UTIs
Mouse infection studies were performed according to the
methods of Johnson et al [83]. Female CBA/J mice (six to ten
weeks of age) were anesthetized and inoculated via transurethral
catheterization with a 20 ml (26109 CFU) challenge inocula per
mouse. Overnight LB cultures for CFT073 and the mutant strain
were pelleted and resuspended in sterile PBS, mixed in equal
number and adjusted to make challenge inocula. To determine the
initial CFU/mL, dilutions of each inoculum were plated onto LB
plates with and without chloramphenicol. After 48 h, the mice
were euthanized and the bladder and kidneys were aseptically
removed, weighed, and homogenized in tubes containing PBS.
Dilutions of the homogenized tissue were then plated onto
duplicate LB plates with and without chloramphenicol or plates
with different antibiotics to determine the bacterial concentration
(CFU/g) of tissue. After overnight incubation, distinct colonies on
plates were enumerated. The numbers of colonies on selective
plates were subtracted from those on LB plates to obtain the
number of wild-type bacteria. In the case of in vivo complemen-
tation studies, recovered bacteria were plated on LB plates with
ampicillin and LB with ampicillin and chloramphenicol. Similarly,
the numbers of colonies on ampicillin and chloramphenicol plates
were subtracted from those on LB plates with ampicillin to obtain
the number of wild-type bacteria. A group of 10 mice for each
dual-strains challenge were used to determine alterations in fitness.
The WT/Dc5041/c5041::Chlr competition assay was performed
twice while other assays were performed once. For statistical
analysis, a two-tailed Wilcoxon matched pairs test was used (Prism
software, CA) and the threshold for statistical significance was a P
value ,0.05.
Supporting Information
Figure S1 Comparison of the proteomes from the WT,
Dc5041 and Dc5040 mutants during growth in human
urine. Whole cell proteins of WT, Dc5041::Chlr, and
Dc5040::Chlr mutants cultured in urine were labeled with cy2,
cy3, and cy5 respectively and analyzed by 2D-DIGE in a single
gel. Red spots represent proteins induced in the mutant as
compared to the WT; green spots indicate proteins repressed in
the mutant as compared to the WT. Differentially expressed
proteins were circled and numbered. (A) Comparison between the
WT and Dc5041::Chlr mutants. Ten proteins were identified to be
differentially expressed. (B) Comparison between the WT and
Dc5040::Chlr mutants. Eleven proteins were identified to be
differentially expressed.
(TIF)
Figure S2 Operon formation represented by reverse
transcription (RT)-PCR results using cDNA and a
negative control without reverse transcriptase. Primers
were designed to span ORFs c5032 & c5034, c5034 & c5035, c5035
& c5036, c5036 & c5037, c5037 & c5038, c5038 & c5039, and
c5039 & c5040. UPEC CFT073 were cultured in M9 medium
containing glycerol as the sole carbon source. RNA was purified
and reverse transcribed to cDNA. The RNA that was not reverse
transcribed served as a negative control.
(TIF)
Figure S3 In vitro growth of island gene mutants in M9
medium containing a-KG as the sole carbon and energy
source under aerobic conditions. Optical density of CFT073
WT and island gene mutants during growth in M9 medium
containing a-KG as the sole carbon source under aerobic
conditions was determined. Growth curves represent the average
measurement at each time point from triplicate experiments.
(TIF)
Figure S4 Effects of C5041 and C5040 on the induction
of target genes on genomic island by a-KG. Wild-type or
mutant bacteria were anaerobically grown in M9 medium
containing glycerol and TMAO in the absence or presence of a-
KG. qRT-PCR expression values in the presence of a-KG are
presented as relative values, as compared to that in the absence of
a-KG. Error bars represent the standard deviations for 3
independent experiments.
(TIF)
Figure S5 The induction of c5038 expression by over-
produced MalE/C5040 fusion protein. The expression of
c5038-lacZ in the WT transformed with the plasmid vector control
(pMAL), pMAL-c5040, or pMAL-malE/c5040 were represented
by the b-Galactosidase activity. IPTG was present at 1 mM for
induction of Ptac promoter.
(TIF)
Table S1 Strains and plasmids. The genotypes of all strains
of E. coli utilized or constructed in this study and information
about the plasmids used in this study.
(DOCX)
Table S2 Oligonucleotides. Oligonucleotide sequences used
as PCR primers.
(DOCX)
Table S3 Prevalence of c5041/c5040 locus among E. coli
isolates.
(DOCX)
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